Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCI Due to AD”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)UnknownNCT04141150
What this trial is testing

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics, LLC 130
Testing effectiveness (Phase 2)Ended earlyNCT04795466
What this trial is testing

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Novartis Pharmaceuticals 34
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Not applicableUnknownNCT05050812
What this trial is testing

The Grounded Brain: How Sleeping Grounded Affects Memory and Perceptions

Who this might be right for
Mild Cognitive ImpairmentChronic Inflammation
California Institute of Integral Studies 8
Large-scale testing (Phase 3)Looking for participantsNCT07169578
What this trial is testing

Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Large-scale testing (Phase 3)Ended earlyNCT01931566
What this trial is testing

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 3,494
Early research (Phase 1)Study completedNCT06114745
What this trial is testing

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)
Atridia Pty Ltd. 2
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Testing effectiveness (Phase 2)Study completedNCT05004688
What this trial is testing

A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Who this might be right for
Mild Cognitive ImpairmentMild DementiaModerate Dementia+1 more
Steven E Arnold, MD 15
Large-scale testing (Phase 3)Looking for participantsNCT07724132
What this trial is testing

An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer Disease Dementia
University College, London 1,200
Early research (Phase 1)Ended earlyNCT03819699
What this trial is testing

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

Who this might be right for
Alzheimer Disease
H. Lundbeck A/S 3
Not applicableStudy completedNCT06151808
What this trial is testing

Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects

Who this might be right for
Alzheimer Disease
Sinotau Pharmaceutical Group 42
Not applicableLooking for participantsNCT07803055
What this trial is testing

Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease

Who this might be right for
Subjective Cognitive Decline (SCD)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseAlzheimer's Disease Dementia+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 48
Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Testing effectiveness (Phase 2)Study completedNCT01965756
What this trial is testing

Effect of Insulin Sensitizer Metformin on AD Biomarkers

Who this might be right for
Alzheimer's DiseaseVascular DementiaDementia+1 more
University of Pennsylvania 20
Testing effectiveness (Phase 2)Looking for participantsNCT06850597
What this trial is testing

Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

Who this might be right for
MCIMCI-AD, Early Stage Alzheimer's DiseaseAlzheimer's Disease
Medical University of Lodz 30
Large-scale testing (Phase 3)Ended earlyNCT01953601
What this trial is testing

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 1,454
Testing effectiveness (Phase 2)Study completedNCT06182085
What this trial is testing

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset
PRInnovation GmbH 304
Early research (Phase 1)Not Yet RecruitingNCT07489599
What this trial is testing

QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease(AD)Mild Cognitive Impairment (MCI)
Qilu Pharmaceutical Co., Ltd. 68
Early research (Phase 1)Study completedNCT04931459
What this trial is testing

Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD

Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 65
Next Page